Science Explorer Back to mapMap
Discussion
Researcher · University Medical Center Utrecht · Netherlands

Jan Herman Veldink

Jan Herman Veldink publishes mostly in Neurology, Molecular Biology and Genetics, on topics such as Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research and Genetic Neurodegenerative Diseases.

ORCID 0000-0001-5572-9657 OpenAlex
World rank
#7,174
of 7,710,434 ranked researchers
Rank in Netherlands
#94
of 107,149
Works
556
Citations
48k
Citations per work
85.5
h-index
108
i10-index 346Top 0.2% in Neurology (Medicine)
Jan Herman Veldink

What does Jan Herman Veldink research?

Jan Herman Veldink's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (28%), Neuroscience (12%).

Life Sciences: 226 works · 40.6% of their workBiochemistry, Genetics and Molecular Biology: 157 works · 28.3% of their workMolecular Biology: 89 works · 16.0% of their workGenetics: 68 works · 12.3% of their workNeuroscience: 68 works · 12.3% of their workCellular and Molecular Neuroscience: 43 works · 7.8% of their workNeurology: 25 works · 4.5% of their workHealth Sciences: 226 works · 40.6% of their workMedicine: 226 works · 40.6% of their workNeurology: 162 works · 29.1% of their workGenetics: 64 works · 11.5% of their workEverything else: 105 works · 18.8% of their workTHEIR WORKJan HermanVeldink556works
Life Sciences41%Health Sciences41%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology15728.3%
    2. Neuroscience6812.3%
    1. Medicine22640.6%
  3. Everything else10518.8%
  1. 1Neurology29% of their works
  2. 2Molecular Biology16% of their works
  3. 3Genetics12% of their works
  4. 4Genetics12% of their works
  5. 5Cellular and Molecular Neuroscience8% of their works
  6. 6Neurology4% of their works

Research topics

Which keywords describe Jan Herman Veldink's research?

The keywords of their largest research topics: Neurodegeneration, FUS/TLS, TDP-43, Mitochondrial Dysfunction, SMN1, Spinal Muscular Atrophy, Genetic Mutations and Huntington's Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Neurodegeneration3853 topics
  2. FUS/TLS2991 topic
  3. TDP-432991 topic
  4. Mitochondrial Dysfunction1874 topics
  5. SMN11581 topic
  6. Spinal Muscular Atrophy1581 topic
  7. Genetic Mutations852 topics
  8. Huntington's Disease681 topic
  9. Protein Aggregation681 topic
  10. Genetic Variation621 topic
  11. Genome-Wide Association621 topic
  12. Brain Iron Accumulation521 topic
  13. Pantothenate Kinase521 topic
  14. DNA Methylation411 topic
  15. Histone Modification411 topic
  16. Parkinson's Disease341 topic
  17. a-Synuclein341 topic
  18. Charcot-Marie-Tooth Disease331 topic
  19. Hereditary Spastic Paraplegia331 topic

Where does Jan Herman Veldink work?

Jan Herman Veldink's main affiliation in the publication record is University Medical Center Utrecht, Netherlands.

How many publications and citations does Jan Herman Veldink have?

OpenAlex counts 556 works and 47,563 citations for Jan Herman Veldink, an h-index of 108, ranking #7,174 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jan Herman Veldink. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.